Scientific Program: August 30

8:30-9:30           IS3R General Assembly (members only)

Session 5: Frontiers

Moderators: M. Fuchsjäger, T. Grist

9:30-9:45        Lecture 1: Agentic AI and AGI: The short- and long-term horizon (E. Kotter)

9:45-9:55        Lecture 2: Blood-based biomarkers, liquid biopsy, AI, and the role of imaging in follow-up
(A. van der Lugt)

9:55-10:05      Lecture 3: New roles for imaging in genetic and cell therapy (R. Weissleder)

10:05-10:15     Lecture 4: Cancer engineering (R. Pettigrew)

10:15-10:40     Controversy: Whole body screening MRI (& low-dose PET) — improved health or
                        increased harm? (S. Reeder)

10:40-11:10     Coffee Break

11:10-11:20     Lecture 5: Can VBR serve as a tool for deployment in an integrated health system?
(J. Brink)

11:20-11:30     Emerging Leader Reflections: Perspectives on challenges, future outlook, necessary
                        resources, and potential solutions (M. Vernooij)

11:30-11:50     Panel summary and perspectives: Translating developing technologies into clinical
                        practice (Rapporteurs: D. Docquier, G. Cerri)
Panelists: B. McNeil, S. Solomon, A. Roncacci, M. Harsh, K. Karti

11:50-12:25     Facilitated Discussion: Frontiers
Moderators: F. Gilbert, O. Clément

12:25-12:30     Outcome and action (M. Fuchsjäger)

Wrap-Up

12:30-12:50     Task forces and symposium follow-up plans (C. Hess)

12:50:13:00     Closing remarks (S. Schönberg)